Skip to main content

Table 1 Cytotoxic effects of Apiole derivatives (AP-02, 04, 05) upon various human breast (MDA-MB-231, ZR75), lung (A549, PE089), liver (Hep G2, Hep 3B), and colon (COLO 205, HT 29) cancer cells

From: Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells

Organ

Tissue Sources

Cell lines

Time (h)

Mean IC50 ± SD (μM)

Apiole

AP-02

AP-04

AP-05

Breast

Human breast cancer

MDA-MB-231

48

NA

227.27 ± 2.90

NA

380.20 ± 3.28

Human breast cancer

ZR-75

48

NA

NA

NA

NA

Human breast epithelial

MCF-10A

48

NA

138.19 ± 2.31

NA

158.66 ± 1.92

Lung

Human lung cancer

A549

48

NA

348.97 ± 2.62

NA

486.03 ± 4.27

Human lung cancer

PE089

48

NA

191.79 ± 2.30

NA

300.66 ± 2.48

Human lung fibroblast

HEL299

48

NA

50.95 ± 0.46

241.44 ± 3.90

91.85 ± 1.25

Liver

Human liver cancer

HepG2

48

NA

206.03 ± 7.37

526.81 ± 0.81

225.33 ± 4.37

Human liver cancer

Hep3B

48

NA

122.92 ± 2.59

NA

322.50 ± 1.47

Rat liver epithelial

Clone 9

48

NA

43.67 ± 0.95

513.89 ± 16.47

374.41 ± 3.95

Mouse liver epithelial

BNL cl.2

48

NA

153.58 ± 0.54

NA

522.62 ± 3.55

Colon

Human colon cancer

Colon 205

48

NA

16.57 ± 0.39

604.34 ± 19.80

133.77 ± 1.32

Human colon cancer

HT-29

48

NA

38.45 ± 1.85

NA

67.65 ± 0.06

Human colon epithelail

FHC

48

NA

263.76 ± 6.31

263.76 ± 4.63

336.47 ± 6.03

  1. NA: IC 50 non-available, * p < 0.05; ** p < 0.01